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ABSTRACT
Toxoplasma gondii virulence depends on the expres-
sion of factors packed into specific organelles such
as rhoptry and microneme. Although virulence factor
expression is tightly regulated, the molecular mech-
anisms controlling their regulation remain poorly un-
derstood. ApiAP2 are a family of conserved tran-
scription factors (TFs) that play an important role
in regulating gene expression in apicomplexan par-
asites. TgAP2XI-5 is able to bind to transcription-
ally active promoters of genes expressed during
the S/M phase of the cell cycle, such as virulence
genes (rhoptries and micronemes genes). We iden-
tified proteins interacting with TgAP2XI-5 including
a cell cycle-regulated ApiAP2 TF, TgAP2X-5. Using
an inducible knock-down strategy and RNA-seq, we
demonstrated that the level of expression of num-
ber of virulence factors transcripts is affected by the
disruption of TgAP2X-5 expression. While TgAP2X-
5 disruption has mild effect on parasite invasion, it
leads to the strain avirulence in mice. To better under-
stand the molecular mechanisms at stake, we inves-
tigated the binding of TgAP2XI-5 at promoters in the
TgAP2X-5 mutant strain in a genome-wide assay. We
show that disruption of TgAP2X-5 expression leads
to defects in TgAP2XI-5 binding to multiple rhoptry
gene promoters. Taken together, these data suggest
a cooperative contribution of two ApiAP2 TF in the
regulation of virulence genes in T. gondii.
INTRODUCTION
Toxoplasma gondii is a unicellular eukaryotic pathogen. It
belongs to the Apicomplexa phylum, which encompasses
some of the deadliest pathogens of medical and veterinary
importance, including Plasmodium (the causative agent of
malaria), Cryptosporidium (responsible for cryptosporidio-
sis) and Eimeria (coccidiosis). Toxoplasma gondii is an ob-
ligate intracellular parasite that leads to the development
of focal central nervous system infections in patients with
HIV/AIDS. In addition, Toxoplasma is also a clinically im-
portant opportunistic pathogen that can cause birth de-
fects in the offspring of newly infected mothers. Toxoplasma
gondii has a complex life cycle, which is characterized by
multiple differentiation steps that are essential for its sur-
vival in both the human and definitive feline host. The com-
mon source of infection for humans is by ingesting either
oocysts shed by infected cats or cyst-contaminated meats.
Sporozoites and bradyzoites are contained in oocyst and
cyst, respectively. These two developmental stages can dif-
ferentiate into rapidly growing tachyzoites, which is the
causative parasitic form responsible for the clinical manifes-
tations in humans. Bradyzoites have the ability to evade the
immune system and resist common drug treatments, there-
fore causing a chronic infection. However, they are also ca-
pable of reverting back to the more virulent tachyzoite stage
in immunocompromised individuals.
As other apicomplexan parasites, T. gondii possesses spe-
cific organelles, namely micronemes and rhoptries, which
contain proteins of critical importance for invasion, the
establishment of the infection and the control of host-
cell expression. These virulence factors are of significance
for many aspects of virulence, for example, certain rhop-
tries proteins are major determinants of virulence in mice
(1). Tachyzoites are able to divide rapidly inside the host
cell through a specific binary replication pattern called en-
dodyogeny (2). In 6 h, T. gondii tachyzoites of the most
virulent Type I strain perform mitosis, assembly of the cy-
toskeletal and membrane elements that form the pellicle,
loading of the growing bud with organelles and finally,
emergence of new, fully formed, invasive daughters from the
mother cell (3). Notably, the parasites cell cycle is divided
in three phases (G1, S and M) while the G2 is apparently
absent (4). The T. gondii cell cycle is a highly coordinated
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process where nuclear division must be synchronized with
the formation of new organelles and their packaging into
a newly formed parasite (4). This process implies a tight
regulation of the expression of the virulence factors that
must be transcribed and translated during a short window
of time when organelles are formed de novo to be trafficked
and packed into them. This was nicely illustrated by the
transcriptome of cell cycle-synchronized tachyzoites show-
ing that most rhoptries and micronemes transcripts have
highly dynamic profiles with a peak of expression during
S and M phases of the cell cycle when the corresponding
organelles are formed de novo (5). As suggested for Plas-
modium (6), Toxoplasma may have adapted a ‘just in time’
mode of expression whereby transcripts and proteins are
produced right when their function is needed (5).
However, how gene expression is controlled in these par-
asites remains poorly understood. A number of sequence-
specific DNA motifs where shown to be important for pro-
moter activity (7). Mechanisms such as epigenetics were
also shown to be involved in T. gondii gene regulation (8, 9).
An analysis of apicomplexan genomes uncovered a family
of putative transcription factors (TF) that are characterized
by the possession of one or more AP2 DNA-binding do-
mains (10). Intriguingly, more than 60 putative AP2 TFs are
currently annotated in the T. gondii genome (www.toxodb.
org) and among them, 24 transcripts appear to be cell cycle
dependent (5). Plasmodium and Cryptosporidium AP2 pro-
teins, which are mostly conserved in T. gondii, were shown
to bind specific DNA motifs using protein-binding microar-
rays and recombinant proteins encompassing their respec-
tive AP2 DNA-binding domains (11). The ability of Plas-
modium ApiAP2 TFs to regulate specific subsets of genes
was underlined in several studies (12–16). Moreover, a com-
prehensive survey of the biological function of P. berghei
ApiAP2 TFs has shown that a large number of genes were
co-regulated by different ApiAP2 TFs, indicating that they
may act in complex to regulate gene expression (17). Re-
cently, multiple T. gondii ApiAP2 TFs were shown to con-
trol cyst formation, indicating that ApiAP2 TFs may play
an important role in T. gondii gene regulation (18–21). How-
ever, the role of T. gondii ApiAP2s in regulating the ex-
pression during the tachyzoite stage remains poorly inves-
tigated. To date, only one T. gondii ApiAP2 TF was shown
to bind to promoters by ChIP–chip assay (22). TgAP2XI-5
binds to transcriptionally active promoters of genes bear-
ing a tachyzoite cell cycle-regulated expression profile peak-
ing during the S/M phase, among which there are a num-
ber of virulence genes (22). Surprisingly, TgAP2XI-5 tran-
script and protein expression profile is unchanged during
the tachyzoite cell cycle, indicating that other mechanisms
could control its cell cycle-regulated biological function. To
address this question, we identified the proteins that were
complexed to TgAP2XI-5 and uncovered its association
with another ApiAP2 TF, TgAP2X-5. We described that
TgAP2X-5, a cell cycle-regulated ApiAP2 TF, is involved
in the regulation of the expression of a number of virulence
factors through its interaction with TgAP2XI-5. These data
are indicative of the presence of cooperative regulation of
virulence genes by an ApiAP2 TF complex in the parasite
T. gondii.
MATERIALS AND METHODS
Parasite tissue culture and manipulation
Tachyzoite of T. gondii type I RHΔhxgprtΔku80 and
RHhxgprtΔku80 TATi strain (containing an anhydrote-
tracycline (ATc)-inducible system and high homologous re-
combination; (23)), were propagated in vitro in human fore-
skin fibroblasts (HFF) using Dulbeccos’s modified Eagles
medium supplemented with 10% fetal calf serum (FCS),
2 mM glutamine and 1% penicillin-streptomycin. Toxo-
plasma gondii tachyzoites were grown in ventilated tissue
culture flasks at 37◦C and 5% CO2. Prior to RNA, protein
purification and for ChIP, intracellular parasites were pu-
rified by sequential syringe passage with 17-gauge and 26-
gauge needles and filtration through a 3-m polycarbonate
membrane filter.
Generation of transgenic T. gondii strains
All primers used for polymerase chain reaction (PCR) are
listed in Supplementary Table S1. Transgenic TgAP2XI-
5-myc, TgAP2X-5-HA and TgHP-HA parasites were gen-
erated with a knock-in strategy. Genomic DNA of type
I RHΔhxgprtΔku80 strain was isolated with the Wizard
Genomic DNA Purification kit (Promega). DNA frag-
ment of 2-kb upstream of the stop codon of TgAP2XI-
5 (TGGT1 216220), TgAP2X-5 (TGGT1 237090) and a
hypothetical protein (HP) TgHP (TGGT1 297460) genes
were amplified using genomic DNA and cloned into ei-
ther pLIC.myc.DHFR or pLIC.3xHA.HXGPRT vectors
(generously provided by Dr Carruthers, U. Michigan) (24).
Transgenes were introduced by electroporation into 10
× 106 freshly egressed tachyzoites of T. gondii strains.
RHΔhxgprtΔku80 strain was transfected with 15 g of
the plasmid pLIC HP-HA (linearized NcoI), pLIC AP2X-
5-HA (linearized ApaI) and/or pLIC AP2XI-5-myc (lin-
earized ApaI). Stable transformants were selected in the
presence of 2 M pyrimethamine (for the DHFR selec-
tion) and 25 g/ml mycophenolic acid and 50 g/ml
xanthine (for the HXGPRT selection). Clonal lines were
obtained by limiting dilution. The TgAP2X-5 inducible
knock-down (iKD) line was generated using a plasmid with
the DHFR cassette containing genomic fragments encom-
passing 2-kb upstream the gene and 2 kb from the pre-
dicted ATG. RHΔhxgprtΔku80 TATi parasites were trans-
fected with 30 g of the iKD digested plasmid (NotI and
ApaI) followed by 2 M pyrimethamine selection. For
complementation, 50 g of a synthetized pUPRT plasmid
containing 3-kb upstream the predicted ATG and the full
length c-myc tagged TgAP2X-5 gene (GeneCust) was co-
transfected with the pSAG1::Cas9-U6::sgUPRT plasmid
(25) in the iKD TgAP2X-5 strain to facilitate the inser-
tion into the uracil phophoribosyltransferase locus. Stable
transgenic and cloned parasites were selected with 5 M 5-
fluoro-2′-deoxyuridine (FUDR). Transgenic TgAP2XI-5-
TAP was generated with a knock-in strategy as described
above by transfecting 15 g of the plasmid pLIC AP2XI-5-
TAP (linearized ApaI) in 10 × 106 TgAP2X-5 iKD and iKD
TgAP2X-5 complemented tachyzoites followed by chlo-
ramphenicol selection (34 mg/ml).
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Parasite growth assay
For parasite growth assay, RHΔhxgprtΔku80 TATi, iKD
TgAP2X-5 and iKD TgAP2X-5 complemented strains were
pre-treated 48 h with ATc. Then, 105 parasites per well in
a 24-well plate were inoculated on HFF monolayer grown
on coverslips for 4 h in normal media or media with ATc
and let grow 29 h, before 4% paraformaldehyde (PFA) fixa-
tion. The number of parasites per vacuole was counted for
100 vacuoles for each condition and performed twice after
TgEno2 staining. Three independent experiments were per-
formed.
Invasion assay
Two-color invasion assay was adapted from (26). Briefly,
2 × 106 freshly egressed tachyzoites were first sedimented
on ice for 30 min on HFF monolayer grown on coverslips
in 24-well plates. Invasion was allowed during 90 min at
37◦C, extensively washed to eliminate unbound parasites
and fixed in 2% PFA in Hank’s Balanced Salt Solution. At-
tached parasites were stained with mouse anti-TgSag1 and
Alexa Fluor-594. After subsequent permeabilization with
0.01% saponin for 15 min, a second staining was performed
using rabbit anti-TgGAP45 and Alexa Fluor-488. The num-
ber of extracellular and intracellular parasites was counted
from nine fields (three times per coverslips) from three in-
dependent biological experiments.
In vivo experiments
A group of 4 female BALB/C mice (7-week-old) were
intraperitoneally injected with 2 × 106 tachyzoites of
parental (RHΔhxgprtΔku80 TATi), iKD TgAP2X-5 and
iKD TgAP2X-5 complemented strains. The drinking water
was supplemented with 0.2 mg/ml of ATc and 5% of su-
crose to suppress TgAP2X-5 HA expression. Survival was
monitored over 15 days. All animal experiments were per-
formed following the Pasteur Institute of Lille guidelines
on animal study board, which conforms to the Amster-
dam Protocol on animal protection and welfare. The animal
work also complied with the French law (no. 87–848 dated
19 October 1987) and the European Communities Amend-
ment of Cruelty to Animals Act 1976. All animals were fed
with regular diet and all procedures were in accordance with
national regulations on animal experimentation and welfare
authorized by the French Ministry of Agriculture and Vet-
erinary committee (permit number: 2016-0049).
Antibodies
The anti-TgEno2 rabbit (27), anti-TgSag1 T41E5 mouse
(28), anti-TgChromo1 mouse (29) and anti-TgGAP45 rab-
bit (kindly provided by Dr Soldati) antibodies were used
in IFA at 1:1000, 1:1000, 1:200 and 1:10 000, respectively.
Anti-HA rabbit (Eurogentech) and rat (Invitrogen) anti-
bodies were used at 1:500 in IFA and in western blots. Anti-
myc mouse (ThermoFisher) was used at 1:200 in IFA and
1:500 in western blot. Anti-TgROP2 mouse T52D1 (kindly
provided by Dr Lebrun) was used at 1:500 in western blot.
Anti-TgActin mouse was used at 1:1000 in western blot.
Immunofluorescence assay and confocal microscopy
Intracellular parasites were fixed with 4% PFA for 15 min,
followed by three phosphate-buffered saline (PBS) washes.
Parasites were permeabilized with 0.1% Triton X-100 in
PBS containing 0.1% glycine for 20 min at room temper-
ature. Samples were blocked with FCS in the same buffer
and the primary antibodies were added on parasites also in
the same buffer for 1 h at room temperature. Secondary an-
tibody coupled to Alexa Fluor-488 or to Alexa Fluor-594
(Molecular probes) diluted at 1:1000 was added in addi-
tion to DAPI for nucleus staining. Confocal imaging was
performed with a ZEISS LSM880 Confocal Microscope or
Apotome Microscope at 63 magnification. All images were
processed using Carl Zeiss ZEN software.
Co-immunoprecipitation
Intracellular parasites (5 × 108 tachyzoites) of the
TgAP2XI-5-myc, TgAP2XI-5-myc/TgAP2X-5-HA
and TgAP2XI-5-myc/TgHP-HA RHΔhxgprtΔku80
strains were purified on a 3-m filter and washed three
times with PBS. The parasite pellet was resuspended
in 1 ml of NEB1 buffer (10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) pH7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM 1,4-Dithiothreitol (DTT), 0.1
mM ethylenediaminetetraacetic acid (EDTA), 0.65% NP40
and 0.5 mM Phenylmethanesulfonyl fluoride (PMSF)),
incubated on ice for 10 min and centrifuged at 1500 × g for
10 min at 4◦C. The pellet was then resuspended with 100 l
of buffer NEB2 (20 mM HEPES pH 7.9, 1.5 mM MgCl2,
420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, 25% glycerol
and 0.5 mM PMSF) for 10 min on ice and centrifuged at 12
000 × g for 10 min at 4◦C. The supernatant was kept as the
nuclear extract. Then, 30 l of beads Pierce™ Anti-c-Myc-
Agarose and Pierce™ HA Epitope Tag Antibody, Agarose
Conjugate (Thermo Scientific) were washed twice with Tris
buffer saline (TBS) 1× solution (50 mM Tris–HCl, 150
mM NaCl and 0.5 mM PMSF) and centrifugated at 2500
× g for 1 min between each wash. Beads were saturated by
using 5 l of bovine serum albumin (1 mg/ml) in 500 l of
TBS 1× under stirring for 15 min at 4◦C, and washed twice
as previously mentioned. The nuclear extract was added to
4 ml of TBS 1× containing the anti-c-Myc or HA Epitope
beads and incubated overnight at 4◦C under stirring. The
next day, beads were washed five times with 3 ml of 1×
TBS-T (1× TBS, 1% Tween and 0.5 mM PMSF) and one
time with 3 ml of final wash buffer (62.5 mM Tris pH 6.8
and 0.5 mM PMSF), by centrifugation at 2500 × g for 1
min between each wash. Immunoprecipitated proteins were
eluted twice with 75 l of elution buffer (62.5 mM Tris pH
6.8, 2% sodium dodecyl sulphate (SDS), 0.1M DTT), then
boiled at 95◦C for 5 min and finally centrifuged at 14 000
× g for 1 min. Both elution were pooled and analyzed by
western blotting before proteomics analysis.
Mass-spectrometry proteomic analysis
After denaturation at 100◦C in 5% SDS, 5% -
mercaptoethanol, 1 mM EDTA, 10% glycerol and 10
mM Tris pH 8 buffer for 3 min, protein samples were
fractionated on a 10% acrylamide SDS-polyacrylamide
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gel electrophoresis gel. The electrophoretic migration was
stopped as soon as the protein sample entered 1 cm into the
separating gel. The gel was briefly labeled with Coomassie
Blue, and five bands, containing the whole sample, were cut.
In gel, digestion of gel slices was performed as previously
described (30).
An UltiMate 3000 RSLCnano System (Thermo Fisher
Scientific) was used for separation of the protein digests.
Peptides were automatically fractionated onto a commer-
cial C18 reversed phase column (75 m × 150 mm, 2 m
particle, PepMap100 RSLC column, Thermo Fisher Scien-
tific, temperature 35◦C). Trapping was performed during
4 min at 5 l/min, with solvent A (98% H2O, 2% ACN
and 0.1% FA). Elution was performed using two solvents
A (0,1% FA in water) and B (0.1% FA in ACN) at a flow
rate of 300 nl/min. Gradient separation was 3 min at 5% B,
37 min from 5% B to 30% B, 5min to 80% B and maintained
for 5 min. The column was equilibrated for 10 min with 5%
buffer B prior to the next sample analysis.
The eluted peptides from the C18 column were analyzed
by Q-Exactive instruments (Thermo Fisher Scientific). The
electrospray voltage was 1.9kV, and the capillary temper-
ature was 275◦C. Full MS scans were acquired in the Or-
bitrap mass analyzer over m/z 300–1200 range with reso-
lution 35 000 (m/z 200). The target value was 5.00E + 05.
Ten most intense peaks with charge state between 2 and 4
were fragmented in the Higher-energy collisional dissocia-
tion (HCD) collision cell with normalized collision energy
of 27%, and tandem mass spectrum was acquired in the Or-
bitrap mass analyzer with resolution 17 500 at m/z 200. The
target value was 1.00E+05. The ion selection threshold was
5.0E+04 counts, and the maximum allowed ion accumula-
tion times were 250 ms for full MS scans and 100 ms for
tandem mass spectrum. Dynamic exclusion was set to 30 s.
Proteomic data analysis
Raw data collected during nanoLC-MS/MS analyses were
processed and converted into *.mgf peak list format
with Proteome Discoverer 1.4 (Thermo Fisher Scientific).
MS/MS data were interpreted using search engine Mas-
cot (version 2.4.0, Matrix Science, London, UK) installed
on a local server. Searches were performed with a toler-
ance on mass measurement of 0.2 Da for precursor and
0.2 Da for fragment ions, against a composite target de-
coy database (50 620 total entries) built with three strains
of T. gondii ToxoDB.org database (strains ME49, GT1 and
VEG, release 12.0, September 2014, 25 264 entries) fused
with the sequences of recombinant trypsin and a list of clas-
sical contaminants (46 entries). Cysteine carbamidomethy-
lation, methionine oxidation, protein N-terminal acetyla-
tion and cysteine propionamidation were searched as vari-
able modifications. Up to one trypsin, missed cleavage was
allowed. For each sample, peptides were filtered out accord-
ing to the cut-off set for proteins hits with peptides taller
than eight residues, ion score > 35, identity score > 10 and
a false positive rate of 0.7%. SAINT analysis was performed
as previously described (31, 32), except that three biological
replicates were used for the bait (TgAP2XI-5-myc) and neg-
ative control (parental strain).
Library preparation and RNA-seq
RNA was extracted as previously described, followed by
genomic DNA removal and cleaning using an RNase-free
DNase I Amplification Grade kit (Sigma). An Agilent 2100
Bioanalyzer was used to assess the integrity of the RNA
samples. Only RNA samples having an RNA integrity score
between 8 and 10 were used. Library preparation was per-
formed using the TruSeq Stranded mRNA Sample Prepa-
ration kit (Illumina) according to the manufacturer’s in-
structions. Libraries were validated using a Fragment Ana-
lyzer and quantified by quantitative PCR (qPCR) (ROCHE
LightCycler 480). Clusters were generated on a flow cell
within a cBot using the Cluster Generation Kit (Illumina),
and libraries were sequenced as 50-bp reads on a HiSeq
2000 using a sequence by synthesis technique (Illumina).
Image analysis and base calling were performed using the
HiSeq control software and real-time analysis component.
Demultiplexing was performed using Illumina’s conversion
software (bcl2fastq 2.17). The quality of the data was as-
sessed using FastQC from the Babraham Institute and the
Illumina software Sequence Analysis Viewer. Potential con-
taminants were investigated with the FastQ Screen software
from the Babraham Institute.
RNA-seq reads were aligned to the T. gondii genome
(ToxoDB-25 TgondiiGT1 Genome.fasta from the ToxoDB
Toxoplasma Genomics Resource, downloaded on 31 Au-
gust 2015) with a set of gene model annotations (ToxoDB-
25 TgondiiGT1.gff from the ToxoDB Toxoplasma Ge-
nomics Resource, downloaded on 31 August 2015) using
the splice junction mapper TopHat 2.0.13 (33). Final read
alignments having more than three mismatches were dis-
carded. Gene counting was performed using HTSeq-count
0.6.1p1 (union mode) (34). Because the data come from a
strand-specific assay, the read must be mapped to the op-
posite strand of the gene. Before statistical analysis, genes
with <15 reads (combining all the analyzed samples) were
filtered out. Differentially expressed genes were identified
using the Bioconductor package edgeR 3.6.7 (35). The data
were normalized using the relative log expression (RLE)
normalization factors. Genes with adjusted P-values <
5% (according to the False discovery rate (FDR) method
from Benjamini–Hochberg) were declared differentially ex-
pressed. The full dataset is deposited at the GEO database
under the accession number GSE106864.
Chromatin immunoprecipitation
ChIP was performed using a protocol previously described
(22) on TgAP2XI-5-TAP, iKD TgAP2X-5/TgAP2XI-5-
TAP and iKD TgAP2X-5 complemented/TgAP2XI-5-
TAP strains. Briefly, intracellular parasites were grown 40 h
with ATc and fixed for 10 min at room temperature using 1%
formaldehyde. DNA was processed by sonication using the
Bioruptor device for 10 min at 4◦C with a 30 s on/off cycle.
Protein–DNA complexes were then diluted in IP Dilution
Buffer (16.7 mM Tris–HCl pH8, 167 mM NaCl, 1.2 mM
EDTA, 0.01% SDS, 1.1% Triton and 0.5 mM PMSF) and
incubated ON with IgG Agarose beads (Amersham Bio-
sciences). The next day, beads were washed five times with
ChIP wash buffer (50 mM Tris–HCl pH8, 250 mM NaCl,
1% NP-40, 1% desoxycholic acid (Fischer Scientific MW
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414.5 Cat.# BP349-100) and 0.5 mM PMSF) and eluted
twice in 75 l of ChIP elution buffer (50 mM NaHCO3 and
1% SDS). ChIP DNA purification was carried out as pre-
viously described in (8). Amplification of immunoprecipi-
tated DNA and 10 ng input DNA was performed using the
GenomePlex® Complete Whole Amplification (WGA) kit
(Sigma). A tilling microarray was designed based on version
6 of the T. gondii ME49 genome (version 7.3) and printed
by Agilent Technologies (22). The microarray encompasses
more than 983 000 features representing the entire genome
with an average coverage of one oligonucleotide every 63
bp. Purified ChIP material was processed according to the
Agilent Mammalian ChIP-on-chip protocol version 10.11,
and labeled DNA was hybridized to an Agilent T. gondii
tiling array for 40 h at 67◦C (G4481-90010; Agilent Tech-
nologies). Microarrays were washed and scanned accord-
ing to the manufacturer’s protocol, and the results were
processed with the Genomic Workbench Standard edition.
The mPeak software (36) was used with default values to
identify peaks among the TgAP2XI-5 ChIP on chip exper-
iments. The full dataset is deposited at the GEO database
under the accession number GSE109086.
Real-time quantitative PCR (RT-qPCR)
All primers were designed using Primer3Plus
(https://primer3plus.com/cgi-bin/dev/primer3plus.cgi)
and are listed in Supplementary Table S1. Tachyzoite
RNA was isolated using Trizol Reagent (cat #15596018,
Invitrogen) according to manufacturer’s protocol, and
purified after an RNase-free DNase I Amplification grade
treatment (Sigma). An Agilent 2100 Bioanalyzer (RNA
6000 Nano kit) was used to assess the integrity of the
RNA samples that were then quantified with a NanoVue
Plus Spectrophotometer (GE Healthcare). Total cDNA
was generated using the Maxima Reverse Transcriptase
kit (Thermo Scientific) with 5 g of total RNA and oligo
(dT) in a final volume of 20 l as recommended by the
manufacturer. Real-time qPCR (RT-qPCR) was performed
using the SYBR® Selected Master Mix (Life technologies)
without ROX according to manufacturer’s instructions,
using 3 M of each primer, ∼10 ng of cDNA in nuclease-
free water to a final volume of 20 l. The Mx3000P system
(Agilent Technologies) was used with the following cycling
conditions: 1 cycle of 50◦C for 2 min, 1 cycle of 95◦C for
10 min, 40 cycles of 95◦C for 30 s, 60◦C for 30 s before
fluorescence detection followed by a dissociation curve
determined with 1 cycle of 95◦C for 1 min, 55◦C for 30 s and
95◦C for 30 s. Quantification cycles (Cq) were determined
using the MxPro qPCR software (Agilent Technologies).
Change in expression of individual genes is represented by
relative fold change in the Cq-values as Cq (TgEno2
served as reference gene). All experiments were performed
on separate biological experiments in duplicate (ChIP) or
triplicate (RNA-seq).
Bioinformatic tools
The Phyre2 web portal (http://www.sbg.bio.ic.ac.uk/
phyre2) (37) was used to produce homology-based
model of the TgAP2X-5 AP2 domain to predict its
three-dimensional structure. The MEME Suite sequence
analysis tool (GOMo application; (38)) and the Regulatory
Sequence Analysis Tools (39) were used to highlight over-
represented motif on promoters of genes downregulated
in iKD TgAP2X-5 strain. Analysis was performed on
the 2000 bp downstream the transcription start as the 5′
untranslated region is not known for all genes identified.
Statistical analysis
All data were analyzed with Graph Pad Prism software (San
Diego, CA, USA). Differences in the means were assessed
by two-way ANOVA and Student’s t-test. In both cases, P
< 0.05 was considered as significant.
RESULTS
TgAP2XI-5 interacts with TgAP2X-5
To identify proteins that may regulate the activity of
TgAP2XI-5, we performed an immunoprecipitation of this
protein using an epitope tagged version of TgAP2XI-5.
The strain expressing TgAP2XI-5-myc was produced using
a knock-in strategy that allowed the tagging of the gene
at its endogenous locus and its expression under its own
promoter. TgAP2XI-5-myc was immunoprecipitated and
the proteins that co-immunoprecipitated were identified by
mass spectrometry analysis (Supplementary Table S2). As
a negative control, we performed the same procedure using
protein extracts from the parental strain. In three experi-
ments, we identified peptides from the TgAP2XI-5 protein
in the IP fraction from the TgAP2XI-5-myc strain but not
from the parental strain (only one peptide was identified in
one of the control experiments). The protein that was identi-
fied as co-immunoprecipitated with TgAP2XI-5-myc in the
three experiments with more than one unique peptide is pre-
sented in Table 1.
We identified peptides originating from another ApiAP2
TF, TgAP2X-5, with the protein extracts from the
TgAP2XI-5-myc strain but not from the parental strain. Af-
ter TgAP2XI-5, TgAP2X-5 presents the highest number of
peptides identified present in the IP fraction and no pep-
tides in the controls. We also ran the SAINT software (31)
to identify the proteins with the highest probability of in-
teracting with TgAP2XI-5. This analysis yielded two pro-
teins with high probability scores (>0.9, see Supplemen-
tary Table S2). TGGT1 260810 was not considered for fur-
ther analysis since it contains a putative transmembrane do-
main. TgAP2X-5 was further characterized. TgAP2X-5 is a
cell cycle-regulated gene as identified by transcriptomics (5)
and using an epitope tagged strain using the knock-in strat-
egy (Figure 1A). Using IFA and a marker of the cell cy-
cle (TgChromo1, a marker of pericentromeric chromatin),
we showed that TgAP2X-5 is a nuclear protein predomi-
nately expressed during the S phase (two centromere dots)
and M phase (two centromere dots and bell-shaped nucleus)
of the cell cycle. TgAP2X-5 expression was barely detectable
during the G1 phase (one TgChromo1 dot) of the cell cy-
cle (Figure 1A). The AP2 domain amino-acid sequence of
TgAP2X-5 is not well conserved in other apicomplexan par-
asites in contrast to that of TgAP2XI-5. However, bioinfor-
matic prediction indicates that it presents the canonical sec-
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Table 1. Identified proteins after TgAP2XI-5-myc protein immunoprecipitation
Total number of peptide
Protein name
Protein accession
numbers
Protein
molecular
weight (Da)
Sample 01
control -
Sample 01
Myc
Sample 02
control -
Sample 02
Myc
Sample 03
control -
Sample 03
Myc
AP2 domain TF AP2XI-5 TGGT1 216220 89 485 25 19 1 20
AP2 domain TF AP2X-5 TGGT1 237090 211 315 3 8 4
The table includes the protein name, accession number, predicted molecular weight and the number of unique peptide identified for each experiment. Three
controls (Control1–3; Parental line immunoprecipitated with the myc antibodies) and immunoprecipitation (AP2XI-5 elution 1–3) experiments were per-
formed. Blank cells represent 0 peptides identified for the corresponding protein. We present here the protein that was identified as co-immunoprecipitated
with TgAP2XI-5-myc in the three experiments with more than one unique peptide.
Figure 1. TgAP2X-5, an ApiAP2 protein is cell cycle-regulated and interacts with TgAP2XI-5. (A) Expression of the TgAP2X-5 protein (anti-HA antibody)
during the tachyzoite cell cycle by confocal imaging. Anti-TgChromo1 antibody was used as marker of the cell cycle. DAPI was used to stain the nucleus.
The cell cycle stage is indicated on the right side of the figure. Scale bar is indicated on the lower right side of each image. (B) TgAP2X-5 interacts with
TgAP2XI-5. Nuclear extract of 3 × 108 parasites for the TgAP2X-5-myc alone (negative control) or the TgAP2X-5-HA/TgAP2X-5-myc strain or TgHP-
HA/TgAP2X-5-myc strain were immunoprecipitated using anti-HA antibodies. The immunoblots were probed with anti-HA antibody (upper panel) to
detect both HA-tagged proteins in the input and eluates. These immunoblots were reprobed with anti-myc antibody (lower panel) to detect the TgAP2XI-
5-myc protein in the input and eluates.
ondary structure features common to AP2 DNA binding
domain with three -strands (contained in one beta-sheet)
and an -helix (Supplementary Figure S1A).
To verify the interaction between TgAP2X-5 and
TgAP2XI-5, we performed a reverse IP using a strain
where both genes are endogenously tagged (TgAP2X-5-
HA and TgAP2XI-5-myc). As a negative control, we also
performed an IP on a strain only expressing TgAP2XI-5-
myc or on a strain expressing TgAP2XI-5-myc and TgHP-
HA, a protein constitutively expressed and not found in
the TgAP2XI-5 co-IPed proteins (Figure 1B). After per-
forming the IP with an anti-HA antibody, we were able to
detect both TgAP2X-5-HA and TgHP-HA proteins (Fig-
ure 1B, upper panel). However, when we probed the same
blots using an anti-myc antibody, only the eluates from the
TgAP2X-5-HA/TgAP2XI-5-myc strain were positive for
the presence of TgAP2XI-5-myc indicating that TgAP2X-5
is indeed able to co-immunoprecipitate TgAP2XI-5 (Figure
1B, lower left panel). We failed to detect TgAP2XI-5 in the
eluates from the strain only expressing TgAP2XI-5-myc or
expressing TgAP2XI-5-myc and TgHP-HA confirming the
specificity of the TgAP2X-5/TgAP2XI-5 interaction. We
also confirmed this interaction using an IP with an anti-
myc antibody (Supplementary Figure S1B) with the same
negative controls.
TgAP2X-5 depletion cause a downregulation of multiple vir-
ulence genes
To better characterize the biological role of TgAP2X-5, we
used a promoter replacement strategy to produce an iKD
mutant strain. In this strain, the expression of the tgap2x-5
transcript is under the control of ATc (Supplementary Fig-
ure S2A). When ATc is added to the culture media, the in-
ducible promoter is repressed and the tgap2x-5 transcript is
no longer produced. We simultaneously added an HA-tag
to the N-terminus of the gene in order to follow the protein
expression (Supplementary Figure S2A). The correct inser-
tion of the construction at the TgAP2X-5 locus was vali-
dated by genomic PCR (Supplementary Figure S2B). West-
ern blots of total protein extracts from this transgenic par-
asite line revealed the expression of a tagged polypeptide at
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the predicted size (210 kDa) in the absence of ATc (Supple-
mentary Figure S2C). In the presence of ATc, we observed
a drastic reduction in the signal from the tagged protein,
with an undetectable level after 48 h of treatment (Sup-
plementary Figure S2C) that was confirmed by RT-qPCR
(Supplementary Figure S2D). We also produced an iKD
TgAP2X-5 complemented strain expressing the TgAP2X-
5-myc-tagged protein from a dispensable locus (uprt) un-
der the control of its own promoter (Supplementary Figure
S3A). In presence of ATc, this strain expressed similar level
of tgap2x-5 transcript than the parental strain as assayed
by RT-qPCR (Supplementary Figure S3B). Moreover, the
cell-cycle expression of TgAP2X-5-myc is conserved with a
peak of expression during the S phase of the cell cycle as
assessed by IFA using TgChromo1 as a cell-cycle marker
(Supplementary Figure S3C).
Since TgAP2X-5 is a potential TF, we examined the dif-
ferential expression of genes when this protein is depleted
(in presence of ATc) by RNA-sequencing (RNA-seq). Total
RNA was purified from tachyzoites of the iKD TgAP2X-5
strain grown under ATc treatment for 48 h (in triplicate).
RNA-seq reads were aligned to the T. gondii genome with
a set of gene model annotations using the splice junction
mapper TopHat 2.0.13. The data were normalized using the
RLE normalization factors. Genes with adjusted P-values
< 5% (according to the FDR method from Benjamini–
Hochberg) were considered differentially expressed. By us-
ing edgeR (35), data analysis revealed significant changes in
the transcription profile in the ATc treated iKD TgAP2X-
5 parasites when compared to the parental, with 153 genes
downregulated and 70 upregulated (Supplementary Table
S3). The predominance of downregulated genes suggests a
potential role for TgAP2X-5 in activation of gene expres-
sion. The majority of the genes with a differential expres-
sion were cell cycle-regulated with a peak of expression dur-
ing the S/M phases of the cell cycle as TgAP2X-5 (Fig-
ure 2A and B). Among them were found transcripts cod-
ing for virulence factors such as rhoptries and micronemes
proteins. We use RT-qPCR to verify the results obtained
by RNA-seq and showed that the selected virulence genes
had their expression downregulated when TgAP2X-5 is de-
pleted while these gene had WT levels (Figure 2C) in the
iKD TgAP2X-5 complemented strain. We also verified that
this transcript downregulation was translating into a de-
creased protein levels. For that, we performed a western-
blot using anti-TgROP2 antibody and showed a drastic re-
duction of TgROP2 expression in the iKD TgAP2X-5 strain
in presence of ATc that returned to the WT level in the
iKD TgAP2X-5 complemented strain (Figure 2D). Of note,
only one annotated rhoptry protein (ROP20) is found in the
overexpressed gene list (Supplementary Table S3).
TgAP2X-5 depletion has a drastic effect on in vivo virulence
To further characterize the defects caused by TgAP2X-5
depletion, we performed standard growth and invasion as-
says (Figure 3). We tested the ability of the parasite to grow
under ATc treatment and recorded the number of para-
sites per vacuole at a given time (Figure 3A). We observed
that the parental strain showed similar growth to that of
the iKD TgAP2X-5 and iKD TgAP2X-5 complemented
strains. This indicates that the growth of the iKD TgAP2X-
5 parasite is not significantly impaired by the absence of
TgAP2X-5 (Figure 3A). We also tested the ability of the
parasites to invade host cells (Figure 3B). In this assay, the
protocol allows to distinguish extracellular parasites that
are attached to the host cell from intracellular parasites af-
ter invasion. While the parental strain with ATc showed
similar number of invaded parasites to that of the iKD
TgAP2X-5 complemented strain, we noticed that the iKD
TgAP2X-5 strain invaded significantly less the host cells
(Figure 3B). Altogether, these data indicate that the para-
sites depleted for TgAP2X-5 are affected in terms of their
invasion ability. We then tested the iKD TgAP2X-5 strain
for virulence in vivo (Figure 3C). As a control, we also in-
fected mice with the parental strain and the iKD TgAP2X-5
complemented strain in presence of ATc. Mice infected with
the iKD TgAP2X-5 strain survived the infection while the
parental and iKD TgAP2X-5 complemented strains were
able to kill mice within 10 days, indicating a drastic effect of
the depletion of the TgAP2X-5 protein on in vivo virulence
(Figure 3C). Mice that survived the iKD TgAP2X-5 strain
infection were indeed infected since their sera responded to
a whole parasite extract in western blots (Supplementary
Figure S4).
TgAP2X-5 depletion prevents TgAP2XI-5 binding to a num-
ber of promoters
By RNA-seq, we showed that TgAP2X-5 regulates directly
or indirectly the expression of number of virulence genes.
We attempted several time to perform chromatin immuno-
precipitation using tagged version of the gene but we re-
peatedly failed to show any enrichment at promoters (Sup-
plementary Figure S5A). Moreover, we were unable to find
any enrichment of a potential DNA motif in the promoter
of genes that were influenced by TgAP2X-5 depletion (Sup-
plementary Figure S5B). Since TgAP2X-5 and TgAP2XI-5
interact (Figure 1), we measured the ability of TgAP2XI-
5 to bind to target promoters in absence of TgAP2X-5 us-
ing a genome-wide assay. We produced ChIP data using a
tagged version of TgAP2XI-5 for the parental strain as well
as for the iKD TgAP2X-5 strain in presence of ATc. As a
negative control, we used the parental strain with an un-
tagged version of TgAP2XI-5 (Supplementary Figure S6).
Using the mPeak software, we found that more than 98%
of the ChIP peaks found in a previously published study
(22) overlapped with the present ChIP data using a tagged
version of TgAP2XI-5. When comparing the TgAP2XI-5
ChIP peaks identified by the mPeak software in presence
and in absence of TgAP2X-5, we found that 92 promot-
ers showed a decrease of TgAP2XI-5 binding in the iKD
TgAP2X-5 strain in presence of ATc (Supplementary Ta-
ble S4) while most of the other TgAP2XI-5 binding sites
remained unaffected (Figure 4A and Supplementary Fig-
ure S6). Among the 153 genes that were downregulated in
absence of TgAP2X-5, only 63 corresponding promoters
are bound by TgAP2XI-5 in normal conditions. Among
these, 13% are downregulated in the TgAP2X-5 mutant and
showed a decreased level of TgAP2XI-5 binding (Supple-
mentary Figure S7 and Table S4). For example, TgROP24
and TgROP15 were downregulated in the TgAP2X-5 mu-
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Figure 2. TgAP2X-5 depletion alters the expression of multiple virulence genes. (A) Pie chart representing the cell-cycle expression of transcripts down-
regulated in the iKD TgAP2X-5 strain compared to parental line under ATc treatment. Peak cell-cycle expression was identified based on available data (5)
and the EdgeR test was used for RNA-seq data processing. The right panel represent the proportion of genes that were annotated as micronemes, rhoptries
or hypotheticals proteins. Others represents gene that were annotated but were not micronemes, rhoptries or hypotheticals proteins. (B) Heat map of all
individual transcript downregulated in the iKD TgAP2X-5 strain presenting an S/M transcription profile according to the cell-cycle expression profiles
(5). (C) Total RNA purified from parental, iKD TgAP2X-5 and iKD TgAP2X-5 complemented strains under ATc treatment were analyzed by RT-qPCR
for ROPs genes. Values are represented as the log2 ratio. Comparison of the relative transcript level was made between the iKD TgAP2X-5 strain and the
parental strain in presence of ATc (green bars), the iKD TgAP2X-5 strain and the iKD TgAP2X-5 complemented strain in presence of ATc (purple bars)
and the parental strain and the iKD TgAP2X-5 complemented strain in presence of ATc (gray bars). RT-qPCR and RNA-seq data are reported in this
graph. A two way ANOVA-test was performed, ****P < 0.0001; **P < 0.01; *P < 0.05; ns P > 0.05 mean ± s.d. (n = 3). (D) Western blot of total protein
extract from parental, iKD TgAP2X-5 and iKD TgAP2X-5 complemented strains in the presence of ATc was probed with anti-myc to detect the presence
of TgAP2X-5 protein expressed from the uprt locus (upper panel). Western were also probed with an anti-TgROP2 antibodies, to detect TgROP2 which
transcript is highly downregulated in the iKD TgAP2X-5 strain (middle panel). TgActin was probed as a loading control (lower panel).
tant and also impacted in terms of binding of TgAP2XI-
5 in the iKD TgAP2X-5 strain in presence of ATc (Figure
4B and C). We confirmed by qPCR the results obtained in
the genome-wide assay for several loci (Figure 4D). We also
confirmed that in the iKD TgAP2X-5 complemented strain,
the level of TgAP2XI-5 binding was similar to the parental
strain (Figure 4D). These results indicate that for a number
of promoters, the binding of TgAP2XI-5 is dependent on
the presence of TgAP2X-5.
DISCUSSION
The complex life cycle of most apicomplexan parasites sug-
gests a tight regulation of gene expression to meet the re-
quirements of changing environments. Transcriptome and
the characterization of promoters studies have shown that
at least, a part of these regulation is based on the tran-
scriptional control of gene expression (7, 40). However, the
characterization of the TFs responsible for the control of
the promoter’s activities remained elusive until the discov-
ery of ApiAP2 TFs and their function in regulating gene
expression. In T. gondii, we described the promoter bind-
ing activity of TgAP2XI-5 which is able to bind to hun-
dreds of promoters of genes transcriptionally active and
mostly regulated during the S/M phase of the cell cycle
(22). Interestingly, TgAP2XI-5 is one of the most conserved
ApiAP2 TF among apicomplexan parasites, not only in the
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Figure 3. TgAP2X-5 depletion has a drastic effect on in vivo virulence. (A) Parasite growth was assayed for parental, iKD TgAP2X-5 and iKD TgAP2X-5
complemented strains under ATc treatment for 24 h. The number of parasite per vacuole was scored for a minimum of 100 vacuoles and the average number
of parasite is represented in this graph. A Student’s t-test was performed, ns P > 0.05; mean ± s.d. (n = 3). (B) Host cell invasion assay. Parental, iKD
TgAP2X-5 and iKD TgAP2X-5 complemented strains pretreated with ATc were allowed to invade host cell for 90 min and then fixed and processed for
a two-color invasion assay. The experiment was performed three-times in triplicate yielding nine measurements. A Student’s t-test was performed, ns P >
0.05; ***P < 0.001; mean ± s.d. (C) Survival of mice infected with parental, iKD TgAP2X-5 and iKD TgAP2X-5 complemented strains was determined
for 15 days under ATc treatment. Mice were infected with 2.106 parasites intraperitoneally.
AP2 DNA binding domain (22), but also in another re-
gion which was identified as a potent trans-activator do-
main (41). TgAP2XI-5 is most likely an activator of tran-
scription of S/M specific genes in T. gondii, as suggested
by its association with active promoters (22). However, its
constitutive protein expression profile (22) suggested that its
activity may be regulated by other proteins. We identified
a cell cycle-regulated ApiAP2 TF, TgAP2X-5, as a poten-
tial partner of TgAP2XI-5. This interaction is specific and
can be direct or indirect. As most of ApiAP2 proteins in T.
gondii, TgAP2X-5 is a large protein with no other recog-
nizable motif than the AP2 DNA binding domain. There-
fore, no potential interaction domain could be identified in
TgAP2X-5. However, when examining the protein regions
that are conserved among coccidian parasites, a region ad-
jacent to the AP2 domain is well conserved while most of
the protein is not (with the exception of the AP2 DNA bind-
ing domain). Interestingly, crystallography of a Plasmodium
falciparum ApiAP2 DNA binding domain suggested that
dimerization of two AP2 domains could occur (42). There-
fore, heterodimerization of two AP2 domains might oc-
cur in the TgAP2XI-5/TgAP2X-5 complex. Further studies
could aim at decipher the function of this potential interac-
tion domain.
Cooperativity of TF is a very common feature on eu-
karyotic promoters to fine tune the level of transcription
of each gene (43). However, it has been poorly explored in
apicomplexan parasites. In P. falciparum, an ApiAP2 pro-
tein recruits a bromo-domain containing protein indicating
that cooperativity of transcriptional regulators takes place
in this parasite (44). In T. gondii, ApiAP2 TFs were found
in complex with chromatin modifiers (45, 46), but interac-
tion of two ApiAP2 was never reported to our knowledge.
Interestingly, identification of the protein associated with
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Figure 4. TgAP2X-5 depletion prevents TgAP2XI-5 binding to a number of promoters. (A) ChIP-on-chip data are represented as the log2 ratio of the
hybridization signal given by DNA immunoprecipitated over the signal given by the non-enriched input DNA. The log2 ratio of each oligonucleotide present
on the tiled microarray has been plotted at the respective genomic position. Genes above the horizontal axis are encoded the forward strand whereas those
below are encoded the reverse strand. The scale of the Y-axis was kept identical for all representation to allow the comparison of signals. TgAP2XI-5 ChIP-
chip assay is represented for the TgAP2XI-5 protein in the parental strain (RHΔhxgprtΔku80, green, negative control) or TgAP2XI-5 tagged strain (red,
positive control) or TgAP2XI-5 tagged in the iKD TgAP2X-5 strain in presence of ATc (orange). The associated peaks identified by the mPeak algorithm
are also provided. A portion of the Toxoplasma gondii chromosome III is represented. The boxed promoter presents a lower enrichment of TgAP2XI-5 in
the iKD TgAP2X-5 strain in presence of ATc. (B) Representation of the ChIP-chip experiments for a portion of chromosome IV which encompasses the
TgROP15 gene (yellow). Two repeats (R1 and R2) are presented for each ChIP experiment along with the mPeak identified peaks. (C) Representation of
the ChIP-chip experiments for a portion of chromosome III which encompasses the TgROP24 gene (yellow). Two repeats (R1 and R2) are presented for
each ChIP experiment along with the mPeak identified peaks. (D) Quantitative PCR was performed on the TgAP2XI-5 ChIP assays performed in the iKD
TgAP2X-5/TgAP2XI-5 strain (orange), iKD TgAP2X-5 complemented/TgAP2XI-5 strain (yellow), TgAP2XI-5-tagged strain (red) and parental strain
(negative control, green). Amplification was carried out on regions within the promoter of each of the six genes listed. The enrichment for corresponding
ChIP DNA samples is presented as a percentage of INPUT for each target.
TgAP2XI-5 did not reproducibly yield chromatin modifiers
or other gene regulation related proteins with the exception
of TgAP2X-5 (although the absence of detection does not
mean the absence of the protein). In Plasmodium, the char-
acterization of ApiAP2 TFs showed that several of these
proteins are able to co-regulate similar set of genes indicat-
ing that cooperativity of ApiAP2 TFs indeed exists in this
parasite (17). Together, these data suggest that cooperativ-
ity may be a widespread mechanism to regulate the activity
of apicomplexan promoters.
TgAP2X-5 depletion alters the ability of TgAP2XI-5 to
bind to number of its target promoters. However, we were
not able to identify genomic regions of significant enrich-
ment of TgAP2X-5 using ChIP-chip. This could be ex-
plained by technical difficulties that hampered our ability
to appropriately perform ChIP with this protein. Alterna-
tively, TgAP2X-5 may not be able to contact DNA with
enough affinity to be detected by this technique. Never-
theless, we cannot exclude that TgAP2X-5 is able to di-
rectly bind DNA. Therefore, TgAP2X-5 may interact with
TgAP2XI-5 but its potential DNA binding activity remain
to be proven. The dependence of TgAP2XI-5 for its DNA
binding to a subset of promoters may therefore depend on
the presence of TgAP2X-5 in the complex through direct or
indirect protein interactions. TgAP2X-5 may also facilitate
the accessibility of TgAP2XI-5 to DNA in a specific chro-
matin environment. Many factors can influence the DNA
binding abilities of a TF on a promoter containing the TF
target sequence, among which DNA unwinding, bending
and chromatin interactions (47). Alternatively, TgAP2X-5
may induce a change of conformation of TgAP2XI-5 allow-
ing the binding to specific promoters. Homodimerization of
the PF14 0633 protein AP2 domain upon DNA binding in-
duces conformational changes in these domains lead by a
domain-swapping mechanism (42). Assuming that AP2 do-
mains of TgAP2XI-5 and TgAP2X-5 interact, this mecha-
nism could lead to increased affinity to selected promoter.
Multi-component TFs are well known in other eukaryotes
among which NF-B that is composed of two subunits (48).
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RNA-seq of TgAP2X-5-depleted parasite revealed
that a subset of virulence factors are downregulated.
Among these, annotated rhoptry (ROP) proteins are
over-represented with fewer microneme (MIC) proteins
present in the list of genes downregulated. This is not
surprising since the timing of expression of these tran-
scripts and proteins is shifted during the S/M phase of
the cell cycle (5), with ROP transcripts being expressed
earlier (during S phase) than the MIC transcripts. This
correlates well with the TgAP2X-5 protein expression
pattern. Similarly, RON proteins, which represent an inter-
mediate expression pattern are not affected by TgAP2X-5
depletion. Number of cell cycle-regulated transcripts
were identified as downregulated in the iKD TgAP2X-5
strain, are annotated as hypothetical and may represent
potential candidates for new ROP proteins. As shown
for the PfAP2-I protein (44), TgAP2X-5 regulates only a
subset of virulence factors indicating that other ApiAP2
may work in concert to regulate the expression of the full
set of ROP and MIC transcripts. The particular subset of
ROPs that are regulated by TgAP2X-5 may be linked by
some functional particularities. For example, they might be
exported together to the newly form organelles as it is the
case for MIC proteins (49).
Nevertheless, the genes regulated by TgAP2X-5 are in-
volved in virulence in vivo since their downregulation is
enough to attenuate the virulence of the mutant parasites.
The lack of apparent phenotype in vitro when testing growth
may be linked to the function of some of the ROP proteins in
manipulating the host cell. Indeed, knock-out for TgROP5,
TgROP16 or TgROP18 did not yield in vitro growth de-
fects but instead drastic virulence phenotypes (50–52). It is
likely that the combination of the downregulation of mul-
tiple genes is the cause of this phenotype as single gene
knock-outs were not enough to produce an avirulent strain.
It is the case for TgROP15, TgROP46 and TgROP47 (53)
and for TgROP13 (54).
The promoter of the transcripts impacted by TgAP2X-5
are not all bound by the TgAP2XI-5 protein (only 42% are
bound by TgAP2XI-5). This indicates that TgAP2X-5 may
interact with other proteins to regulate those genes. Alter-
natively, it may directly bind to the promoter of these genes.
Taken together, these data indicate that the regulation of
gene expression in apicomplexan parasites is probably de-
pendent on the crucial involvement of numbers of TF regu-
lating the same promoters. This implies that transcriptional
regulation of gene expression in these parasites is a multi-
factorial process which probably involves TFs, chromatin
modification and remodeling enzymes and regulation of Pol
II activity on the promoters.
We showed here that two ApiAP2 TFs play a crucial role
in regulating virulence factors expression in the apicom-
plexan parasite T. gondii. The presence of TgAP2X-5 at the
right timing and in the right amount allows the efficient
binding of TgAP2XI-5 to certain promoters. This is the first
evidence of cooperation of ApiAP2 TF for the regulation of
gene expression.
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